Research workbench
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR
Analyse Antibodies specifically targeting a locally misfolded region of tumor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 3G5Z
- Type
- protein
- Length
- 430 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 175 light chain; 175 heavy chain
- Pockets
- 6 · best druggability 0.63
Structure
x-ray diffraction · 2 distinct chains · 3% helix, 49% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 175 light chain | protein | 213 | 3% helix, 50% strand | — |
| B | 175 heavy chain | protein | 217 | 3% helix, 49% strand | — |
Pockets
6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 581 | 0.63 | 0.75 | 51 | empty |
| 2 | 110 | 0.39 | 0.75 | 23 | empty |
| 3 | 84 | 0.38 | 0.77 | 18 | empty |
| 4 | 87 | 0.31 | 0.73 | 22 | empty |
| 5 | 54 | 0.29 | 0.75 | 13 | empty |
Interfaces
1 interface between chains.
- A–B · 2008 Ų buried · 13 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
- 3G5Z · Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 3G5Z · PDBe 3G5Z
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.